73. Interim Resistance Analysis of Long-Acting Lenacapavir in Treatment-Naïve People with HIV at 28 Weeks

por VanderVeen, Laurie, Margot, Nicolas, Naik, Vidula, Chang, Silvia, Martin, Ross, Dvory-Sobol, Hadas, Rhee, Martin, Callebaut, Christian
Publicado 2021

937. Virally Suppressed PLH Switching From Abacavir to Tenofovir Alafenamide Did Not Have Changes in Immune Activation or Inflammation

por Funderburg, Nicholas, Mccomsey, Grace, Kulkarni, Manjusha, Bowman, Emily R, Gabriel, Janelle, Snyder, Brandon, Mallon, Patrick, Winston, Alan, Sengupta, Devi, Yan, Mingjin, Rhee, Martin S, Das, Moupali
Publicado 2018

Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor

por Fisher, Martin, McDonald, Cheryl, Moyle, Graeme, Martorell, Claudia, Ramgopal, Moti, Laplante, Francois, Curley, Joanne, Graham, Hiba, Tran-Muchowski, Cecilia, Liu, Yapei, Rhee, Martin, Szwarcberg, Javier
Publicado 2014

Efficacy and Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in HIV-infected, Virologically Suppressed Black and Non-Blacks Adults Through Week 96: Subgroup Analy...

por Flamm, Jason A, Vanig, Thanes, Gathe, Joseph, Kinder, Clifford, Para, Michael, Rashbaum, Bruce, Segal-Maurer, Sorana, Shamblaw, David, Wohlfeiler, Michael, Young, Benjamin, Zurawski, Christine, Rhee, Martin S
Publicado 2017

Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years

por Gazzard, Brian, Marie Girard, Pierre, Di Perri, Giovanni, Gallant, Joel, Towner, William, Rogatto, Felipe, Demorin, Jennifer, McColl, Damian, Liu, Hui, Rhee, Martin, Szwarcberg, Javier, Piontkowsky, David
Publicado 2014

1585. Efficacy and safety of long-acting subcutaneous lenacapavir in heavily treatment-experienced people with multi-drug resistant HIV: Week 52 results

por Ogbuagu, Onyema, Segal-Maurer, Sorana, Ratanasuwan, Winai, Trottier, Benoit, Brunetta, Jason, Shirasaka, Takuma, Koenig, Ellen L, Wang, Hui, Margot, Nicolas A, Dvory-Sobol, Hadas, Rhee, Martin S, Baeten, Jared, Molina, Jean-Michel
Publicado 2022

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults

por Raffi, François, Orkin, Chloe, Clarke, Amanda, Slama, Laurence, Gallant, Joel, Daar, Eric, Henry, Keith, Santana-Bagur, Jorge, Stein, David K., Bellos, Nicholaos, Scarsella, Anthony, Yan, Mingjin, Abram, Michael E., Cheng, Andrew, Rhee, Martin S.
Publicado 2017

1581. Weight and Metabolic Changes with Long-Acting Lenacapavir in a Combination Regimen in Treatment-Naïve People with HIV-1 at Week 80

por Kumar, Princy N, Goldstein, Deborah A, Hengel, Richard L, Gaur, Aditya H, Wurapa, Anson K, Khalsa, Ann M, Newman, Cheryl L, Saunders, Gary, Liu, Shan-Yu, Dvory-Sobol, Hadas, Rhee, Martin, Gupta, Samir K
Publicado 2023

1596. Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multi-Drug Resistant HIV: Week 104 Results

por Ogbuagu, Onyema, DeJesus, Edwin, Berhe, Mezgebe, Richmond, Gary J, Ruane, Peter J, Sinclair, Gary I, Ramgopal, Moti N, Sanchez, William, Crofoot, Gordon E, Margot, Nicolas A, Wang, Hui, Dvory-Sobol, Hadas, Rhee, Martin, Baeten, Jared, Segal-Maurer, Sorana
Publicado 2023